Fig. 8

MiR-770 could significantly inhibit the DOX resistance and metastasis of triple negative breast cancer cells, which is mediated via regulation of apoptosis and EMT and modification of tumor associated macrophages
MiR-770 could significantly inhibit the DOX resistance and metastasis of triple negative breast cancer cells, which is mediated via regulation of apoptosis and EMT and modification of tumor associated macrophages